Here four things to know:
1. Mr. Link sold the shares at $44.46 per share.
2. The total value of transaction was $333,450.
3. The 52-week high of the shares is $51.23 and the 52-week low is $31.35.
4. NuVasive received an average rating of “buy” for the short term.
More articles on devices:
NuVasive, Medtronic patent saga continues — 5 key updates
InVivo goes from illiquid to a top-traded stock: 5 key notes
6 key notes on Mazor Robotics’ short interest decline
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
